Vitamin D supplements are essential for all those who have low level of vitamin D in blood. Vitamin D deficiency can cause breast and prostate cancer.
The deficiency of vitamin D can cause various problems in both men and women. Vitamin D deficiency can cause breast and prostate cancer. Hence, all those men and women who have have low level of vitamin D in blood, should take vitamin D supplements.
Don't Miss: The Best CES 2017 Gadgets
A new study also proves that vitamin D help fight breast cancer in women. The higher level of vitamin D in women's blood will guard them against breast cancer. Hence the use of vitamin D supplements are beneficial for women.
A new study by University of California, San Diego School of Medicine researchers proves that breast cancer patients with high levels of vitamin D in their blood are twice as likely to survive the disease as women with low levels of vitamin D. This study has been published in the March issue of Anti-Cancer Research.
Previously, Professor in the Department of Family and Preventive Medicine, Cedric F. Garland, conducted a study which proved that women with low vitamin D levels are at higher risk to get premenopausal breast cancer. And this study questioned the link between vitamin D and breast cancer survival rates.
However in a new study, Garland and other researchers of San Diego School of Medicine analyzed 4,443 breast cancer patients. They checked the level of vitamin D in these patients at the time of diagnosis in five different studies.
"Vitamin D metabolites increase communication between cells by switching on a protein that blocks aggressive cell division," said Garland. "As long as vitamin D receptors are present tumor growth is prevented and kept from expanding its blood supply. Vitamin D receptors are not lost until a tumor is very advanced. This is the reason for better survival in patients whose vitamin D blood levels are high."
Garland advised physicians that they should consider adding vitamin D into a breast cancer patient's standard care now and then closely monitor the patient.
"There is no compelling reason to wait for further studies to incorporate vitamin D supplements into standard care regimens since a safe dose of vitamin D needed to achieve high serum levels above 30 nanograms per milliliter has already been established," said Garland.
Garland also urged breast cancer patients to use vitamin D supplements. And he also said the patients should ask their health care provider to check their levels of vitamin D before substantially increasing vitamin D intake.
"The study has implications for including vitamin D as an adjuvant to conventional breast cancer therapy," said co-author Heather Hofflich, DO, UC San Diego Associate Professor in the Department of Medicine.